Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Heterogeneity of the action potential duration is required for sustained atrial fibrillation
Uma Mahesh R. Avula, … , Steven O. Marx, Elaine Y. Wan
Uma Mahesh R. Avula, … , Steven O. Marx, Elaine Y. Wan
Published April 25, 2019
Citation Information: JCI Insight. 2019;4(11):e128765. https://doi.org/10.1172/jci.insight.128765.
View: Text | PDF
Research Article Cardiology Cell biology

Heterogeneity of the action potential duration is required for sustained atrial fibrillation

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for substantial morbidity and mortality. Recently, we created a mouse model with spontaneous and sustained AF caused by a mutation in the NaV1.5 channel (F1759A) that enhances persistent Na+ current, thereby enabling the investigation of molecular mechanisms that cause AF and the identification of potentially novel treatment strategies. The mice have regional heterogeneity of action potential duration of the atria similar to observations in patients with AF. In these mice, we found that the initiation and persistence of the rotational reentrant AF arrhythmias, known as spiral waves or rotors, were dependent upon action potential duration heterogeneity. The centers of the rotors were localized to regions of greatest heterogeneity of the action potential duration. Pharmacologically attenuating the action potential duration heterogeneity reduced both spontaneous and pacing-induced AF. Computer-based simulations also demonstrated that the action potential duration heterogeneity is required to generate rotors that manifest as AF. Taken together, these findings suggest that action potential duration heterogeneity in mice and humans is one mechanism by which AF is initiated and that reducing action potential duration heterogeneity can lessen the burden of AF.

Authors

Uma Mahesh R. Avula, Jeffrey Abrams, Alexander Katchman, Sergey Zakharov, Sergey Mironov, Joseph Bayne, Daniel Roybal, Anirudh Gorti, Lin Yang, Vivek Iyer, Marc Waase, Deepak Saluja, Edward J. Ciaccio, Hasan Garan, Andrew R. Marks, Steven O. Marx, Elaine Y. Wan

×

Figure 5

Inhomogeneity of the APD is required for AF in F1759A-dTG mice.

Options: View larger image (or click on image) Download as PowerPoint
Inhomogeneity of the APD is required for AF in F1759A-dTG mice.
(A–C) Re...
(A–C) Representative APD50 maps in sinus rhythm before (vehicle), after 500 μM ranolazine, and after 20 nM ATX-II. Scale bar: 1 mm. (D) Graph depicting relationship between APD and APD dispersion before (vehicle) and after either 500 μM ranolazine or 20 nM ATX-II. ***P < 0.001; ****P < 0.0001 by 1-way ANOVA and Dunnett’s multiple-comparisons test. The color and direction of the brackets indicate the pair of comparisons. (E) Representative time-space plot of LA and LV during 10-Hz atrial pacing after 500 μM ranolazine. Scale bar: 500 ms. (F) Graph depicting relationship between number of EADs/min and percentage of EADs causing AF before (vehicle) and after either ranolazine or ATX-II. *P < 0.05 and ****P < 0.0001 by 1-way ANOVA and Dunnett’s multiple-comparisons test. The color and direction of the brackets indicate the pair of comparisons. (G) Representative time-space plot of LA and LV during 10-Hz atrial pacing after 20 nM ATX-II. EADs are marked by *. Horizontal scale bar: 500 ms. Vertical scale bar: 2.5 mm. Electrogram shows EADs. Scale bar: 100 ms. (H) Representative APD50 maps in sinus rhythm before (vehicle), after 500 μM ranolazine, and after ranolazine and 0.9 μM digoxin. (I) Graph depicting relationship between APD and APD dispersion before (vehicle) and after either 500 μM ranolazine or 500 μM ranolazine and 0.9 μM digoxin. ***P < 0.001; ****P < 0.0001 by 1-way ANOVA and Dunnett’s multiple-comparisons test. The color and direction of the brackets indicate the pair of comparisons. (J) Representative time-space plot of LA and LV during 10-Hz atrial pacing after ranolazine and digoxin. Afterdepolarizations are marked by asterisks. (K) Electrogram shows EADs and DADs. (L) Graph depicting relationship between number of afterdepolarizations/min and percentage of afterdepolarizations causing AF before (vehicle) and after either ranolazine or ranolazine and digoxin. The color and direction of the brackets indicate the pair of comparisons. (M) Automaton simulation of fibrillatory activity in atrial tissue. (Upper) A uniform APD gradient of 100 ms was imposed. (Lower) Two APDs were imposed: 100 ms and 130 ms. Electrical activation was initiated by an S1–S2 pulse with 84-ms coupling interval from the lower right-hand grid corner (node set to state 1 for each pulse; see Methods). No reentry was seen in a homogeneous uniform gradient. In the nonuniform simulation, activation by an S1–S2 pulse caused fibrillatory activity in the form of rotors at the boundary between the 2 APD gradients of 100 and 130 ms.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts